Delivery Order SPE2DB22D1106-SPE2DB24FFGL8
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 100 capsules of the drug Tamsulosin Hydrochloride 0.4 mg to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,088.68 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, on August 16, 2024, with a completion date of August 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,081.48 firm fixed-price delivery order is for the supply of 4,565,546,920 units of Tamsulosin Hydrochloride 0.4 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award is for the supply of 4,566,816,352 units of the drug Tamsulosin HCL 0.4 mg capsules, valued at $1,087.28, with a completion date of January 2, 2025. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It is not designated with a set-aside requirement,...
This federal contract award is a delivery order valued at $1,443.94, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a performance period ending on May 15, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA). The contract, valued at $2,265.22, is a delivery order with a firm fixed price. The award date is October 8, 2024, and the ultimate completion date is October 9, 2024. This contract is not a set-aside. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts by...
This federal contract award, valued at $1,912.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,683,725 units of Tamsulosin HCl 0.4 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is set for September 5, 2024. The contract was not set aside for a specific business type. This award is likely part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $1,636.98 and an ultimate completion date of May 13, 2024. The contract is a Delivery Order and was awarded on May 10, 2024 with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,604.24 for the delivery of 4,565,471 units of the prescription drug Tamsulosin Hydrochloride 0.4 mg Capsules. The contract, issued by the Defense Logistics Agency (DLA), is a Delivery Order type with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this...
This federal contract award, valued at $1,897.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,758,933 units of Tamsulosin HCL 0.4 mg capsules, a medication used for the treatment of benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 19, 2024. No set-aside designation was...